Recuren Plus Arnica Bruise Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Recuren Plus Arnica Bruise Cream
Generic name: ARNICA MONTANA 7%
Manufacturer: REGENEREN PLUS LTD
Product type: HUMAN OTC DRUG
SPL set ID: 3dbe6e5b-1ca7-6941-e063-6294a90ab042
SPL ID: 4a9eb08e-37b7-3b05-e063-6394a90aa2bb
Version: 2
Effective date: 2026-02-12
Source export date: 2026-09-28
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:39:06

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Recuren Plus Arnica Bruise Cream	openfda.brand_name
generic name		ARNICA MONTANA 7%	openfda.generic_name
manufacturer name		REGENEREN PLUS LTD	openfda.manufacturer_name
ndc	package	87014-002-01	openfda.package_ndc
ndc	product	87014-002	openfda.product_ndc
ndc11	package	87014000201	derived:openfda.package_ndc
spl id		4a9eb08e-37b7-3b05-e063-6394a90aa2bb	id
spl set id		3dbe6e5b-1ca7-6941-e063-6294a90ab042	set_id
unii		O80TY208ZW	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only. if you are allergic to Arnica Montana or any of the ingredients. Avoid contact with eyes, mucous membranes, or broken skin. Stop use and ask a doctor if condition worsens or symptoms persist for more than 3 days. Keep out of reach of children. In case of ingestion, seek medical help or contact a Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.